Reducing the Risk of Cardiovascular Diseases in Community-dwelling Adults: an Ambispective Cohort Study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cardiovascular Diseases
- Sponsor
- Nanfang Hospital, Southern Medical University
- Enrollment
- 20000
- Locations
- 2
- Primary Endpoint
- Major adverse cardiovascular events
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
To establish and evaluate a new prediction model for assessing cardiovascular disease risk in community-dwelling adults.
Detailed Description
This is an ambispective, observational cohort study. In the retrospective part, we will enroll residents from Guangzhou or Foshan who participated in the annual health checks provided by the Chinese National Basic Public Health Service project between January 2015 and December 2019. The demographic characteristics, anthropometric measurements, laboratory assays, medical history, living habits, and medications will be collected through personal electronic health records obtained from the regional chronic disease management platform. In the prospective part, residents who participated in the annual health checks provided by the Chinese National Basic Public Health Service project after January 2020 will be enrolled. In addition to the data collected in the retrospective part, blood, urine and fecal samples and lifestyle questionnaires will be collected for further analysis. All participants will be followed-up till December 2025. A new prediction model for assessing cardiovascular disease risk will be established and evaluated.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Meet at least one of the following conditions:
- •Age ≥ 65 years;
- •Diabetes mellitus;
- •Hypertension;
Exclusion Criteria
- •Refuse to provide informed consent;
Outcomes
Primary Outcomes
Major adverse cardiovascular events
Time Frame: 5 years
Major adverse cardiovascular events include all-cause mortality, acute myocardial infarction, coronary heart disease, heart failure and stroke.
Secondary Outcomes
- Cognitive dysfunction(5 years)
- Atherosclerotic cardiovascular events(5 years)
- All-cause mortality(5 years)
- Renal functional deterioration(5 years)
- Renal replacement therapy and/or death due to acute renal failure(5 years)
- Incident atrial fibrillation(5 years)